Smead Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $297M | Sell |
2,471,398
-366,902
| -13% | -$42.4M | 6.47% | 3 |
|
|
2025
Q4 | $299M | Sell |
2,838,300
-196,374
| -6% | -$18.4M | 6.2% | 2 |
|
|
2025
Q3 | $255M | Sell |
3,034,674
-232,644
| -7% | -$19.2M | 4.92% | 6 |
|
|
2025
Q2 | $259M | Sell |
3,267,318
-67,248
| -2% | -$5.35M | 5.18% | 4 |
|
|
2025
Q1 | $299M | Buy |
3,334,566
+34,356
| +1% | +$3.21M | 5.13% | 5 |
|
|
2024
Q4 | $328M | Sell |
3,300,210
-80,259
| -2% | -$8.27M | 5.09% | 6 |
|
|
2024
Q3 | $384M | Buy |
3,380,469
+421,646
| +14% | +$50.1M | 5.48% | 5 |
|
|
2024
Q2 | $366M | Sell |
2,958,823
-88,152
| -3% | -$11.4M | 5.72% | 4 |
|
|
2024
Q1 | $402M | Buy |
3,046,975
+124,503
| +4% | +$15.3M | 6.27% | 3 |
|
|
2023
Q4 | $319M | Buy |
2,922,472
+11,572
| +0.4% | +$1.2M | 5.71% | 5 |
|
|
2023
Q3 | $300M | Sell |
2,910,900
-99,873
| -3% | -$10.8M | 6.12% | 4 |
|
|
2023
Q2 | $347M | Sell |
3,010,773
-37,019
| -1% | -$4.2M | 6.9% | 4 |
|
|
2023
Q1 | $324M | Buy |
3,047,792
+69,193
| +2% | +$7.47M | 6.46% | 2 |
|
|
2022
Q4 | $330M | Buy |
2,978,599
+255,497
| +9% | +$26.1M | 7.07% | 2 |
|
|
2022
Q3 | $235M | Buy |
2,723,102
+43,226
| +2% | +$3.86M | 6.1% | 4 |
|
|
2022
Q2 | $244M | Buy |
2,679,876
+157,342
| +6% | +$13.9M | 6.25% | 4 |
|
|
2022
Q1 | $207M | Buy |
2,522,534
+391,023
| +18% | +$30.8M | 4.8% | 8 |
|
|
2021
Q4 | $163M | Buy |
2,131,511
+397,372
| +23% | +$31.7M | 4.25% | 12 |
|
|
2021
Q3 | $130M | Buy |
1,734,139
+38,828
| +2% | +$2.95M | 4.46% | 11 |
|
|
2021
Q2 | $132M | Buy |
1,695,311
+135,892
| +9% | +$10.1M | 4.62% | 8 |
|
|
2021
Q1 | $115M | Buy |
1,559,419
+822,494
| +112% | +$60.7M | 5.05% | 6 |
|
|
2020
Q4 | $57.5M | Sell |
736,925
-33,142
| -4% | -$2.53M | 3.33% | 13 |
|
|
2020
Q3 | $61M | Sell |
770,067
-80,946
| -10% | -$6.34M | 3.86% | 10 |
|
|
2020
Q2 | $62.8M | Sell |
851,013
-72,597
| -8% | -$5.47M | 3.96% | 11 |
|
|
2020
Q1 | $67.8M | Sell |
923,610
-46,214
| -5% | -$3.63M | 4.81% | 8 |
|
|
2019
Q4 | $84.2M | Buy |
969,824
+12,888
| +1% | +$1.06M | 3.74% | 12 |
|
|
2019
Q3 | $76.9M | Sell |
956,936
-27,476
| -3% | -$2.2M | 3.76% | 15 |
|
|
2019
Q2 | $78.8M | Sell |
984,412
-24,834
| -2% | -$1.9M | 3.79% | 13 |
|
|
2019
Q1 | $80.1M | Sell |
1,009,246
-26,163
| -3% | -$1.96M | 4.06% | 12 |
|
|
2018
Q4 | $75.5M | Sell |
1,035,409
-42,338
| -4% | -$2.99M | 3.95% | 13 |
|
|
2018
Q3 | $73M | Sell |
1,077,747
-28,922
| -3% | -$1.84M | 3.29% | 16 |
|
|
2018
Q2 | $64.1M | Sell |
1,106,669
-20,561
| -2% | -$1.16M | 3.05% | 18 |
|
|
2018
Q1 | $58.6M | Sell |
1,127,230
-698
| -0.1% | -$37.7K | 2.84% | 19 |
|
|
2017
Q4 | $60.6M | Sell |
1,127,928
-53,166
| -5% | -$2.95M | 2.76% | 20 |
|
|
2017
Q3 | $72.2M | Sell |
1,181,094
-15,773
| -1% | -$956K | 3.44% | 13 |
|
|
2017
Q2 | $73.2M | Sell |
1,196,867
-28,130
| -2% | -$1.71M | 3.53% | 14 |
|
|
2017
Q1 | $74.3M | Sell |
1,224,997
-24,305
| -2% | -$1.47M | 3.74% | 14 |
|
|
2016
Q4 | $70.2M | Sell |
1,249,302
-160,342
| -11% | -$9.38M | 3.56% | 14 |
|
|
2016
Q3 | $83.9M | Sell |
1,409,644
-87,139
| -6% | -$5.1M | 4% | 11 |
|
|
2016
Q2 | $82.3M | Sell |
1,496,783
-91,755
| -6% | -$4.88M | 3.86% | 14 |
|
|
2016
Q1 | $80.2M | Sell |
1,588,538
-125,252
| -7% | -$6.13M | 3.46% | 14 |
|
|
2015
Q4 | $71.8M | Buy |
1,713,790
+438,864
| +34% | +$22.1M | 3.2% | 18 |
|
|
2015
Q3 | $60.1M | Buy |
1,274,926
+285,354
| +29% | +$15.2M | 3.21% | 19 |
|
|
2015
Q2 | $53.8M | Buy |
989,572
+104,305
| +12% | +$5.85M | 3.51% | 14 |
|
|
2015
Q1 | $48.6M | Buy |
885,267
+141,534
| +19% | +$8.01M | 3.57% | 14 |
|
|
2014
Q4 | $40.3M | Sell |
743,733
-101,032
| -12% | -$5.63M | 3.71% | 12 |
|
|
2014
Q3 | $47.8M | Buy |
844,765
+14,567
| +2% | +$818K | 5.15% | 5 |
|
|
2014
Q2 | $45.8M | Buy |
830,198
+38,181
| +5% | +$2.08M | 4.99% | 4 |
|
|
2014
Q1 | $42.9M | Buy |
792,017
+97,493
| +14% | +$5.05M | 5.17% | 5 |
|
|
2013
Q4 | $33.2M | Buy |
694,524
+201,008
| +41% | +$9.19M | 4.57% | 9 |
|
|
2013
Q3 | $22.4M | Buy |
493,516
+76,671
| +18% | +$3.5M | 3.64% | 11 |
|
|
2013
Q2 | $18.5M | Buy |
+416,845
| New | +$18.6M | 3.74% | 12 |
|
Other funds holding MRK
VCM
VPM
Smead Capital Management's MRK Position: Q1 2026 in Review
Smead Capital Management reduced its Merck (MRK) stake by 13% in Q1 2026, selling an estimated $42.4M and leaving 2,471,398 shares worth $297M. The position accounts for 6.47% of the portfolio, ranked #3.
Smead Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $402M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Smead Capital Management held 2,471,398 shares of Merck worth $297M as of Q1 2026.
- Smead Capital Management sold 366,902 Merck shares in Q1 2026, an estimated $42.4M.
- Merck made up 6.47% of Smead Capital Management's portfolio in Q1 2026, its #3 holding.
- Smead Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Smead Capital Management's Merck position peaked at $402M in Q1 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Smead Capital Management's 13F filing for Q1 2026, filed 14 May 2026.